PSGCX | VSGAX | PSGCX / VSGAX | |
Total Expense Ratio | 2.10 | 0.07 | 3,000% |
Annual Report Gross Expense Ratio | 2.10 | 0.07 | 3,000% |
Fund Existence | 19 years | 14 years | - |
Gain YTD | -19.181 | 7.876 | -244% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.59B | 39.1B | 4% |
Annual Yield % from dividends | 0.00 | 0.56 | - |
Returns for 1 year | -30.16 | 10.54 | -286% |
Returns for 3 years | -27.97 | 58.02 | -48% |
Returns for 5 years | -58.46 | 31.57 | -185% |
Returns for 10 years | 30.06 | 149.39 | 20% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SDEM | 27.72 | 0.07 | +0.27% |
Global X MSCI SuperDividend® Em Mkts ETF | |||
IWV | 377.24 | -0.05 | -0.01% |
iShares Russell 3000 ETF | |||
KMLM | 27.12 | -0.05 | -0.18% |
KraneShares Mount LucasMgdFutsIdxStgyETF | |||
NFEB | 27.15 | -0.09 | -0.32% |
Innovator Growth-100 Pwr Buffr ETF - Feb | |||
LABU | 107.36 | -0.59 | -0.55% |
Direxion Daily S&P Biotech Bull 3X ETF |